Circulating CD137(+) T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer

PURPOSE: CD137 molecule is expressed by activated lymphocytes, and in patients with cancer identifies the tumor-reactive T cells. In solid tumors, high levels of circulating CD137(+) T cells are associated with the clinical response and the disease-free status. Here, we examined the role of the CD13...

Descripción completa

Detalles Bibliográficos
Autores principales: Zizzari, Ilaria Grazia, Di Filippo, Alessandra, Botticelli, Andrea, Strigari, Lidia, Pernazza, Angelina, Rullo, Emma, Pignataro, Maria Gemma, Ugolini, Alessio, Scirocchi, Fabio, Di Pietro, Francesca Romana, Rossi, Ernesto, Gelibter, Alain, Schinzari, Giovanni, D'Amati, Giulia, Rughetti, Aurelia, Marchetti, Paolo, Nuti, Marianna, Napoletano, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377756/
https://www.ncbi.nlm.nih.gov/pubmed/34980602
http://dx.doi.org/10.1158/1078-0432.CCR-21-2918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377756/
https://www.ncbi.nlm.nih.gov/pubmed/34980602
http://dx.doi.org/10.1158/1078-0432.CCR-21-2918

Ejemplares similares